True sector experts across Healthcare
The healthcare industry faces rapidly evolving market dynamics. Ever-changing regulatory, competitive and technological forces add layers of complexity in each sector and geographical market.
We help investors and companies to answer the core commercial questions by cutting through these layers with our understanding of each stakeholder in the value chain.
Private oncology services in the UK is primarily chemotherapy (67%), which is almost entirely funded by PMI. Only ~3% of the market is self pay. The cases most likely to be addressed privately are those affecting younger patients on average, such as breast cancer.
Demand for non-surgical aesthetic procedures has been increasing rapidly since 2019, with significant investor interest. Traditional cosmetic surgeries have also seen a post-pandemic surge after years of flat demand.
The UK has long had fewer imaging scanners compared to peers, especially in MRI and CT. With growing demand there remains opportunity for investors across the value chain from manufacturing and distribution to provision of care (image generation and interpretation).
The IVF market has been attractive owing to demand growth driven by improving technologies and social changes, as well as resiliance to economic downturn. Key trends include the expansion of investor-backed international groups like IVIRMA and the rise of ‘low cost’ providers.
NHS mental health inpatient capacity has been kept flat as reliance on community mental health services has increased in order to address increasing demand.
Investors have been active in ophthalmology services in the UK with key examples being SpaMedica and Optegra. It is an area with strong underlying demographic demand drivers and where the NHS has actively used private specialist providers to address waiting lists. Private providers now complete over 50% of all NHS-funded cataract surgeries.
Opticians is a highly consolidated space in the UK dominated by large players like Specsavers and Vision Express. Key recent developments include the emergence of more premium fashion-focussed chains, and challenger consolidators like Hakim Group. Robust underlying drivers include the ageing population and increasing demand for higher-priced fashion items.
Private hospitals and clinics represent ~6% of total acute healthcare spending in the UK.
In the second of our two-part series on vendor commercial due diligence (VCDD), Adam Scott,
senior partner, and Abhishek Patel, engagement manager, at Mansfield Advisors, discuss how
to effectively engage with advisors to create a compelling narrative for buyers
Ellie Wee, junior analyst, and Victor Chua, senior partner look at how private ophthalmology has increased volumes without compromising on quality
In the first of a two-part series on vendor commercial due-diligence Adam Scott and Abhishek Patel look at why doing it right can drive better outcomes for sellers.
As LaingBuisson publishes new research on the changes shaping primary care services
and the role of the independent sector, Mansfield Advisors senior partner Adam Scott and
clinical fellow Gargi Pandey look at the opportunities for private investment.
German-speaking countries have a thriving market for post-operative rehabilitation, but in the UK only a handful of providers have dipped their toes into what remains shallow water. Max Taylor and Adam Scott find out more.
Occupational health has become a hot topic in recent years, driven by a tight labour market, a strained NHS and higher long-term sickness rates following the pandemic. Employee health and wellbeing is now even higher on the corporate agenda which has spurred market growth and investor activity. Ali Bahram and Adam Scott explain key market trends and how investors are viewing the space
